Endonovo Therapeutics, Inc. (ENDV)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
Jul 31, 2025, 1:07 PM EDT

Endonovo Therapeutics Statistics

Total Valuation

ENDV has a market cap or net worth of 241,323.

Market Cap241,323
Enterprise Value n/a

Important Dates

The last earnings date was Friday, June 27, 2025.

Earnings Date Jun 27, 2025
Ex-Dividend Date n/a

Share Statistics

ENDV has 1.21 billion shares outstanding.

Current Share Class 1.21B
Shares Outstanding 1.21B
Shares Change (YoY) n/a
Shares Change (QoQ) -77.91%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.94
PB Ratio -0.01
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.00

Current Ratio 0.00
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2.15

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -144.27%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 11.44%
Revenue Per Employee 255,723
Profits Per Employee -4.40M
Employee Count 1
Asset Turnover 0.23
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -81.82% in the last 52 weeks. The beta is -1.96, so ENDV's price volatility has been lower than the market average.

Beta (5Y) -1.96
52-Week Price Change -81.82%
50-Day Moving Average 0.00
200-Day Moving Average 0.00
Relative Strength Index (RSI) 51.50
Average Volume (20 Days) 7,784,225

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.09

Income Statement

In the last 12 months, ENDV had revenue of 255,723 and -4.40 million in losses. Loss per share was -0.06.

Revenue255,723
Gross Profit 246,034
Operating Income -2.62M
Pretax Income -4.40M
Net Income -4.40M
EBITDA -1.97M
EBIT -2.62M
Loss Per Share -0.06
Full Income Statement

Balance Sheet

Cash & Cash Equivalents n/a
Total Debt 7.06M
Net Cash -7.06M
Net Cash Per Share -0.01
Equity (Book Value) -22.96M
Book Value Per Share -0.07
Working Capital -23.66M
Full Balance Sheet

Cash Flow

Operating Cash Flow -629,904
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 96.21%
Operating Margin -1,023.16%
Pretax Margin -1,722.23%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ENDV does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -130.88%
Shareholder Yield n/a
Earnings Yield -1,825.00%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on December 20, 2019. It was a reverse split with a ratio of 0.001.

Last Split Date Dec 20, 2019
Split Type Reverse
Split Ratio 0.001

Scores

ENDV has an Altman Z-Score of -159.34 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -159.34
Piotroski F-Score 4